Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2019-04-02 | Deborah L. Kilpatrick, Ph.D. Age 51 Occupation: Chief Executive Officer of Evidation Health, Inc., a digital health company, since 2014; Vice President of Market Development and Chief Commercial Officer of CardioDx, a genomic diagnostics company from 2006 to 2014 with responsibility for sales, marketing, and reimbursement from insurers; Held multiple leadership roles at Guidant Corporation, a medical device company, from 1998 to 2006 (acquired by Boston Scientific), including Research Fellow, Director of R&D, and Director of New Ventures in the Vascular Intervention Division; Serves on the College of Engineering Advisory Boards for Georgia Tech and the California Polytechnic State University, and is a Fellow of the American Institute of Medical and Biological Engineering; Holds multiple patents in medical device technologies and drug delivery devices; Advises multiple venture capital funds and privately-held startup companies in the digital health and health care sectors. Director Since 2018 Board committees: Audit Committee Director Compensation: $166,384 in total for 2018 fiscal year. |
| 2020-03-31 | Deborah L. Kilpatrick, Ph.D. Age 52 Occupation: Chief Executive Officer of Evidation Health, Inc. Committees: Audit Committee. Director Compensation: $191,998. |
| 2021-03-30 | Deborah L. Kilpatrick, Ph.D. Age 53 Director since 2018 The current members of each of the Board committees are identified in the table below. Director Audit Committee Management Development and Compensation Committee Corporate Governance and Nominating Committee Deborah L. Kilpatrick, Ph.D. X X The following table summarizes the total compensation paid or earned by each of the non-employee members of our Board of Directors for the 2020 fiscal year ended January 2, 2021. Deborah L. Kilpatrick, Ph.D. $85,353 $54,142 $18,154 $120 $157,769 |
| 2023-03-30 | Deborah L. Kilpatrick, Ph.D. Age 55 Director since 2018 The Audit Committee is comprised entirely of independent Directors, currently including Barbara R. Matas (Chair), Stephen L. Gulis, Jr., Julie M. Howard, Deborah L. Kilpatrick, Ph.D. and Angel L. Mendez. The Management Development and Compensation Committee (the Compensation Committee) is comprised entirely of independent Directors, currently including Brenda J. Lauderback (Chair), Daniel I. Alegre, Phillip M. Eyler, Julie M. Howard and Jean-Michel Valette. |
Data sourced from SEC filings. Last updated: 2025-12-06